Navigation Links
Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
Date:8/31/2007

p>Initially, the trial court dismissed the lawsuit, finding that the dispute was governed exclusively by the federal Medicare Act. That ruling meant that the hospitals had no other remedy but to pursue their 6,000 individual claims through a lengthy federal administrative process. A Texas court of appeals affirmed the trial court decision.

However, the Texas Supreme Court found that "requiring Hospitals to exhaust administrative remedies before coverage decisions have been made would turn the administrative scheme on its head ... "

The Court reversed the court of appeals decision and remanded the case to the trial court to determine Aetna's contractual obligations to the hospitals.

The hospital systems are represented by Scott Clearman and Brian Walsh of McClanahan & Clearman, L.L.P., and David Warden and Eric Chenoweth of Yetter & Warden, L.L.P., in Houston.

For more information about this case, contact Scott Clearman of McClanahan & Clearman at 713-223-2005 or 713-304-9669 or Mike Androvett at 214-507-5456 or mike@legalpr.com.


'/>"/>
SOURCE McClanahan & Clearman
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. A Baffling New Drug Plan In Texas Town
2. Texas Lends a Hand for “Own Your Future” Health Campain
3. Smoking in Public Places Banned, In Texas
4. North Texas Surgeons Lead Robotically Assisted Laparoscopic Surgeries.
5. Texas Requires Cancer Vaccine for Girls
6. Texas Youth Commission Reeling Under Multiple Charges
7. Students of Texas A&M University Going Trans-Fat Free
8. Texas Lawmakers Give The Boot To Cervical Cancer Vaccine
9. Texas Passes Bill To Halt Order Mandating HPV Vaccine for School Girls
10. Mother Hangs Herself and Three Children in Texas
11. Seven Children Ordered Removed from Squalid Home in Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
... old was declared brain dead in a hospital in Hyde... the organs of their loved one. // MOHAN (Multi Or...s were called in and they provided the family with...s were being undertaken. It was late evening befor...
...e men hailing from the Dudu Town of India’s Rajast...high fluoride content in its water. The excessive ...lems in the people living in the area.// 'I have ... efforts to find brides for them have failed due t...
...ty reducing drugs are awaiting FDA approval and if...tures with high profits due to sales of these drug...al regulators before it could be available as a co...are the two new anti-obesity drugs and could help ...
...tion is reported in two Chinese province of Ningxi... to threaten Asia which is already facing outbreak...umans is rare // but they cause immense economic l...burden of the farmers who are already facing loss ...
Other Medicine News:Health News:A first in Liver Transplant in India – Networking works wel 2Health News:Polluted Water Prevents Men From Getting Married 2
(Date:9/3/2008)...and GENEVA, Sept. 3 /- Artelis SA and... based monoclonal antibody,production with the ach...per liter. This record level was accomplished by a...high-performance stable Selexis CHO,production cel...tists at,Selexis SA using their proprietary Selexi...
(Date:9/3/2008)...ny to Discuss Phase 3 Plans with FDA, PRINCETON, ...Inc.,announced today that it successfully complet...he company,s new, innovative low-dose, once-weekly... by its internal product,code AG-200-15. The Phase...,primary endpoint of ovulation suppression, cycle ...
(Date:9/3/2008)...uated in Repeat-Dosing Study in Subjects with ALS,... -- Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) ann... trial (SB-509-801) to evaluate its drug, SB-509, ...motor-neuron disease for which there,are limited t...-509, is an injectable formulation of a plasmid,en...
(Date:9/2/2008)... /-, - This Analysis Showe...of Stroke by 34% in Patients With Atrial Fibrillat...y Antithrombotic Therapy, The results of a post-h... presented today at the clinical trial update sess... 2008, in Munich, Germany. Previous results,from t...
Breaking Medicine Technology:Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Biotage Launches New 24 Well Pyrosequencing 28R 29 System 4286 1Biotage Launches New 24 Well Pyrosequencing 28R 29 System 4286 2Turn that frown upside down healthy gums are something to smile about 15548 1Turn that frown upside down healthy gums are something to smile about 15548 2Scientists 3A New technique identifies molecular biomarkers for disease 15546 1Scientists 3A New technique identifies molecular biomarkers for disease 15546 2Scientists 3A New technique identifies molecular biomarkers for disease 15546 3Ohio Faith Leaders Call on Sen Voinovich to Cosponsor Legislation to Protect Kids From Tobacco 15544 1Ohio Faith Leaders Call on Sen Voinovich to Cosponsor Legislation to Protect Kids From Tobacco 15544 2
...ous administration show potential for,new option t...e 04, 2007 /PRNewswire-FirstCall/ -- Millennium,Ph...on of positive,data for VELCADE, the market-leadin...who have received at least one prior therapy.,Thes...ubcutaneous,(SC) administration of VELCADE, a new ...
... With Follicular Lymphoma Reported,Today at ASCO A...wire/ -- GlaxoSmithKline plc,announced today long-...le one-week course of frontline treatment with the...dine I-131 Tositumomab) in,76 patients with newly ...ma (NHL). This regimen was found to induce durable...
Other Medicine Technology:New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 2New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 3New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 4New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 5New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 6New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 78-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
...nd medium volume laboratories, as well as specialt...simplicity and flexibility needed to respond to mu... the Elecsys 1010 system enables operators to hand...e testing without sacrificing ease of operation or...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t
...stry System provides high-performance detection te...c proteins and therapeutic drugs. It also delivers...ow the laboratory to streamline its operations and...esign enables numerous functions to be performed s...
The Embla 384 cell washer is a top-loading, robotic-compatible microplate washer for high throughput screening. It is designed specifically for cell-based assays, which require a gentler wash, but ca
Medicine Products: